Copy
View this email in your browser
Share Share
Tweet Tweet
Forward Forward

The Web's Daily Resource for Huntington's Disease News

In the 12/26/2022 edition:

New RNA-targeting Therapy Reduces Toxic HTT Protein Buildup

By Patricia Inácio, PhD on 12/20/2022

A mouse rests in a researcher's hand next to a set of test tubes.Researchers have developed a new therapy that reduced the toxic buildup of the mutant huntingtin (HTT) protein — the hallmark of Huntington’s disease — in lab-grown neurons from Huntington’s patients and in a mouse model of the disease. The CRISPR-based therapy was designed to specifically target the HTT gene’s messenger RNA (mRNA), the blueprint molecule derived […]

The post New RNA-targeting Therapy Reduces Toxic HTT Protein Buildup appeared first on Huntington's Disease News.

Continue Reading

More Recent Articles:

Being Silly and Creating Memories Can Make Life With HD Bearable
Study Finds How Branaplam May Work to Help Treat Huntington’s
My Wife Worries About Only Being Remembered as Her ‘HD Self’
Abnormal Red Blood Cells Found in 4 Chinese Huntington’s Patients
Farewell, Baby Girl: Grieving the Loss of Our Beloved Dog

Follow us on social media for access to exclusive content!
Facebook
LinkedIn
Copyright © 2022 BioNews Inc., All rights reserved.




Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.